Tag: COVID-19
Business & Industry
Building Resilient Pharma Portfolios in an Era of Scientific and Market Uncertainty
Pharmaceutical companies are radically redesigning portfolio strategies to survive a "triple threat" environment of scientific complexity, regulatory upheaval like the IRA, and capital scarcity. This analysis explores the shift from efficiency-driven models to resilience-first frameworks, detailing how leaders are embedding optionality into pipelines, embracing modality agnosticism, and using dynamic resource allocation to thrive amidst volatility.
Clinical Trials
Nipah Virus Vaccines Enter Clinical Trials in Bangladesh
Two Vaccines against the Nipah virus, a deadly bat-borne virus, are scheduled to begin human clinical trials in Bangladesh, while intriguing medication candidates have...
Drug Research
Nasal Administration Could Boost HIV And COVID-19 Vaccines
A team led by an assistant professor from the University of Minnesota in the US has created a new method to successfully administer vaccines through...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read